Sihuan Pharmaceutical Holdings Group (0460) Stock Statistics & Valuation Metrics

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of HK$8.30B. The enterprise value is HK$4.19B.

Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.28%.

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is 38.4. Sihuan Pharmaceutical Holdings Group’s PEG ratio is -0.30.

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of 2.62B and earned 179.70M in profits. Earnings per share was 0.02.

In the last 12 months, operating cash flow was -21.36M and capital expenditures -58.33M, giving a free cash flow of -79.69M billion.

Sihuan Pharmaceutical Holdings Group pays an annual dividend of HK$0.011, resulting in a dividend yield of 0.87%

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Sep 1, 2026, TBA (Confirmed).

Sihuan Pharmaceutical Holdings Group as a current ratio of 1.80, with Debt / Equity ratio of 17.20%

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid 231.75M in taxes.

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is 11.71, with an EV/FCF ratio of -34.50.

Sihuan Pharmaceutical Holdings Group has HK$4.10B in cash and marketable securities with HK$1.01B in debt, giving a net cash position of HK$3.09B billion.

Gross margin is 68.83%, with operating margin of 23.19%, and net profit margin of 6.86%.

The average price target for Sihuan Pharmaceutical Holdings Group is HK$1.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy